BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 38683513)

  • 1. Macroscopic tumor dimension, sentinel lymph node outcome, and survival analysis among cutaneous melanoma.
    Asato MA; Moraes-Neto FA; Moraes MPT; Ocanha-Xavier JP; Alencar Marques ME; Xavier-Junior JCC
    Int J Dermatol; 2024 Jun; 63(6):765-772. PubMed ID: 38217520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary Sentinel Lymph Node: An Original Staging Approach in Cutaneous Melanoma.
    Pina LN; Graneros LE; Montesinos MF; Eiben GA; Barrios Jirsa SD; Avagnina MA; Paradeda ME; Sinagra DL; Montesinos MR
    J Cutan Med Surg; 2024; 28(3):287-289. PubMed ID: 38353148
    [No Abstract]   [Full Text] [Related]  

  • 3. Sentinel lymph node biopsy for melanoma in the older population: A prospective analysis of outcomes.
    Kadhum M; Mayr L; Pope-Jones S; Cubitt J; Hemington-Gorse S
    J Surg Oncol; 2024 Jun; 129(7):1202-1208. PubMed ID: 38436610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil to lymphocyte ratio: lack of association with sentinel lymph node biopsy status and relapse-free survival in cutaneous melanoma patients.
    Meves ES; Meves A
    Int J Dermatol; 2023 Jun; 62(6):e329-e330. PubMed ID: 35959518
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to investigation of prognostic factors for non-sentinel lymph node metastasis in patients undergoing sentinel lymph node biopsy for cutaneous malignant melanoma: Experience from a reference centre in Turkey Journal of Plastic, Reconstructive & Aesthetic Surgery [Volume 91, April 2024, Pages 167-172].
    Yalcin CE; Melenkis S; Demir L; Okur FT; Sagir MS; Ercan A
    J Plast Reconstr Aesthet Surg; 2024 May; 94():210. PubMed ID: 38820690
    [No Abstract]   [Full Text] [Related]  

  • 6. Single centre experience with magtrace in cutaneous melanoma in six patients.
    Correia Duarte M; Hemington-Gorse SJ; Cubitt JJ
    J Plast Reconstr Aesthet Surg; 2024 Jun; 93():183-184. PubMed ID: 38703706
    [No Abstract]   [Full Text] [Related]  

  • 7. Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature.
    Svedman FC; Pillas D; Taylor A; Kaur M; Linder R; Hansson J
    Clin Epidemiol; 2016; 8():109-22. PubMed ID: 27307765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma.
    Kyrgidis A; Tzellos T; Mocellin S; Apalla Z; Lallas A; Pilati P; Stratigos A
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD010307. PubMed ID: 25978975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of prognostic factors for non-sentinel lymph node metastasis in patients undergoing sentinel lymph node biopsy for cutaneous malignant melanoma: Experience from a reference centre in Turkey.
    Yalcin CE; Melenkis S; Demir L; Okur FT; Sagir MS; Ercan A
    J Plast Reconstr Aesthet Surg; 2024 Apr; 91():167-172. PubMed ID: 38417393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence factors in patients with cutaneous melanoma and positive sentinel lymph node treated in a single reference unit in Buenos Aires.
    Nardi WS; Toffolo Pasquini M; Tomé F; Vigovich F; Cora MF; Quildrian SD
    Medicina (B Aires); 2024; 84(2):279-288. PubMed ID: 38683513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).
    Broman KK; Hughes T; Dossett L; Sun J; Kirichenko D; Carr MJ; Sharma A; Bartlett EK; Nijhuis AAG; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; Frank J; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Farma JM; Deneve JL; Fleming MD; Perez MC; Lowe MC; Olofsson Bagge R; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras J; Teras RM; Farrow NE; Beasley G; Hui JYC; Been L; Kruijff S; Kim Y; Naqvi SMH; Sarnaik AA; Sondak VK; Zager JS
    Cancer; 2021 Jul; 127(13):2251-2261. PubMed ID: 33826754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.
    Lee DY; Lau BJ; Huynh KT; Flaherty DC; Lee JH; Stern SL; O'Day SJ; Foshag LJ; Faries MB
    J Am Coll Surg; 2016 Jul; 223(1):9-18. PubMed ID: 27236435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current management of patients with cutaneous melanoma with a positive sentinel lymph node.
    Quildrian SD; Nardi WS; Scasso V; Novas C; Bella Quero L; Silva C
    Medicina (B Aires); 2023; 83(3):376-383. PubMed ID: 37379534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete lymph node dissection or observation in melanoma patients with multiple positive sentinel lymph nodes: A single-center retrospective analysis.
    Persa OD; Knuever J; Mauch C; Schlaak M
    J Dermatol; 2018 Oct; 45(10):1191-1194. PubMed ID: 30095864
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.